Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
diabetic nephropathy
microalbuminuria
serum Cystatin-C
type 1 diabetes mellitus
urinary Cyclophilin-A
Journal
Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
03
01
2020
revised:
07
03
2020
accepted:
02
04
2020
pubmed:
19
4
2020
medline:
15
7
2021
entrez:
19
4
2020
Statut:
ppublish
Résumé
Currently, microalbuminuria is the gold standard for detection and prediction of diabetic nephropathy (DN). However, microalbuminuria appears once significant kidney damage has actually occurred. We investigated the diagnostic role of urinary Cyclophilin-A (uCypA), uCypA/creatinine ratio (uCypA/Cr) and serum Cystatin-C (sCysC) as biomarkers for early detection of DN in children with type 1 diabetes mellitus (T1DM) of short duration (2-5 years) before microalbuminuria emerges. uCypA, uCypA/Cr, and sCysC levels were assessed in three age- and sex-matched groups; microalbuminuric diabetic group (n = 31), normoalbuminuric diabetic group (n = 29), and control group (n = 30). Glomerular filtration rate was estimated (eGFR) based on both serum creatinine (eGFR-Cr) and sCysC (eGFR-CysC). Significantly higher sCysC and lower eGFR-CysC were detected in both diabetic groups compared to controls and in microalbuminuric compared to normoalbuminuric group. No detected significant difference in eGFR-Cr values across the studied groups. Both uCypA and uCypA/Cr were significantly elevated in microalbuminuric compared to both normoalbuminuric and control groups with no difference between normoalbuminuric and control groups. Prediction of microalbuminuria was conducted using sCysC with area under curve up to 0.980. Combined use of sCysC and uCypA had better diagnostic value than uCypA alone. sCysC is a promising early biomarker for DN in childhood T1DM before albuminuria detection. eGFR-CysC is superior to eGFR-Cr in evaluating renal status in childhood T1DM. uCypA and uCypA/Cr were useful tools in predicting microalbuminuria, although not regarded as diagnostic biomarkers for early-stage DN in T1DM children by the current study.
Sections du résumé
BACKGROUND
Currently, microalbuminuria is the gold standard for detection and prediction of diabetic nephropathy (DN). However, microalbuminuria appears once significant kidney damage has actually occurred.
OBJECTIVES
We investigated the diagnostic role of urinary Cyclophilin-A (uCypA), uCypA/creatinine ratio (uCypA/Cr) and serum Cystatin-C (sCysC) as biomarkers for early detection of DN in children with type 1 diabetes mellitus (T1DM) of short duration (2-5 years) before microalbuminuria emerges.
METHODS
uCypA, uCypA/Cr, and sCysC levels were assessed in three age- and sex-matched groups; microalbuminuric diabetic group (n = 31), normoalbuminuric diabetic group (n = 29), and control group (n = 30). Glomerular filtration rate was estimated (eGFR) based on both serum creatinine (eGFR-Cr) and sCysC (eGFR-CysC).
RESULTS
Significantly higher sCysC and lower eGFR-CysC were detected in both diabetic groups compared to controls and in microalbuminuric compared to normoalbuminuric group. No detected significant difference in eGFR-Cr values across the studied groups. Both uCypA and uCypA/Cr were significantly elevated in microalbuminuric compared to both normoalbuminuric and control groups with no difference between normoalbuminuric and control groups. Prediction of microalbuminuria was conducted using sCysC with area under curve up to 0.980. Combined use of sCysC and uCypA had better diagnostic value than uCypA alone.
CONCLUSION
sCysC is a promising early biomarker for DN in childhood T1DM before albuminuria detection. eGFR-CysC is superior to eGFR-Cr in evaluating renal status in childhood T1DM. uCypA and uCypA/Cr were useful tools in predicting microalbuminuria, although not regarded as diagnostic biomarkers for early-stage DN in T1DM children by the current study.
Substances chimiques
Biomarkers
0
Cystatin C
0
Cyclophilin A
EC 5.2.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
846-855Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(suppl 1):S67-S74.
Arora MK, Singh UK. Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update. Vascul Pharmacol. 2013;58(4):259-271.
Mogensen C, Christensen C, Vittinghus E. The stages in diabetic renal disease: with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(suppl 2):64-78.
Zabeen B, Nahar J, Islam N, Azad K, Donaghue K. Risk factors associated with microalbuminuria in children and adolescents with diabetes in Bangladesh. Indian J Endocrinol Metab. 2018;22(1):85-88.
Donaghue KC, Wadwa RP, Dimeglio LA, et al. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2014;15(suppl 20):257-269.
Cohen-Bucay A, Viswanathan G. Urinary markers of glomerular injury in diabetic nephropathy. Int J Nephrol. 2012;2012:146987.
Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 64). Kidney Int. 2003;63(1):225-232.
Tramonti G, Kanwar YS. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy. Endocrine. 2013;43(3):494-503.
MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G. Nonalbuminuric renal insufficiency in type 2 diabetes. Diabetes Care. 2004;27(1):195-200.
Zachwieja J, Soltysiak J, Fichna P, et al. Normal-range albuminuria does not exclude nephropathy in diabetic children. Pediatr Nephrol. 2010;25(8):1445-1451.
Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford regional prospective study Group. Diabetes Care. 1999;22(3):495-502.
Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia. 1990;33(8):470-476.
Halimi J-M. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients. Diabetes Metab. 2012;38(4):291-297.
Matheson A, Willcox MD, Flanagan J, Walsh BJ. Urinary biomarkers involved in type 2 diabetes: a review. Diabetes Metab Res Rev. 2010;26(3):150-171.
Gudehithlu KP, Hart PD, Vernik J, et al. Peptiduria: a potential early predictor of diabetic kidney disease. Clin Exp Nephrol. 2019;23(1):56-64.
Gurley SB, Ghosh S, Johnson SA, et al. Inflammation and immunity pathways regulate genetic susceptibility to diabetic nephropathy. Diabetes. 2018;67(10):2096-2106.
Gluhovschi C, Gluhovschi G, Petrica L, et al. Urinary biomarkers in the assessment of early diabetic nephropathy. J Diabetes Res. 2016;2016:1-13.
Kamijo-Ikemori A, Sugaya T, Kimura K. Novel urinary biomarkers in early diabetic kidney disease. Curr Diab Rep. 2014;14(8):513.
MacIsaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014;63(2):S39-S62.
Zhang D, Ye S, Pan T. The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes. PeerJ. 2019;7:e7079.
Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med. 1999;37(4):389-395.
Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-226.
Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-a meta-analysis. Clin Biochem. 2007;40(5-6):383-391.
Shankar RK, Dolan LM, Isom S, et al. Serum cystatin C in youth with diabetes: the SEARCH for diabetes in youth study. Diabetes Res Clin Pract. 2017;130:258-265.
Rohani F, Hooman N, Moradi S, Mobarra M, Najafizadeh M. Glomerular filtration rate-based cystatin C compared to microalbuminuria to detect early stage of diabetic nephropathy in children with type 1 diabetes mellitus. Int J Diabetes Dev Ctries. 2015;35(3):342-348.
Tsai S-F, Su C-W, Wu M-J, et al. Urinary Cyclophilin A as a new marker for diabetic nephropathy: a cross-sectional analysis of diabetes mellitus. Medicine. 2015;94(42):e1802.
Ramachandran S, Venugopal A, Charles S, et al. Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes. Proteomics. 2012;12(18):2808-2821.
Ryffel B, Woerly G, Greiner B, Haendler B, Mihatsch M, Foxwell B. Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology. 1991;72(3):399-404.
El-Saeed GK, El-Deen WAS, Montasr BA, Omar TA, Mohamed DS. Urinary podocalyxin and cyclophilin A: markers for early detection of type 2 diabetic nephropathy. Menoufia Med J. 2019;32(3):996.
Harun H, Lunesia R, Azmi S. Correlation between urinary Cyclophilin A and urinary albumin levels on diabetic kidney disease. Indones J Kidney Hypertension. 2019;2(2):10-16.
Amer HMA, Sabry IM, Bekhet MMM, Mohammed RNS. The role of urinary cyclophilin A as a new marker for diabetic nephropathy. Egypt J Hosp Med. 2018;70(9):1431-1439.
El-Ziny MA, Al-Marsafawy HM, El-Hagar MM, Chalaby N, El-Sherify E. Growth parameters and adiposity in Egyptian infants and children. Egypt J Commun Med. 2003;21:63-73.
Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51(3):170-179.
Falkner B, Daniels SR, Flynn JT, et al. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;14(2 III):555-576.
Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4(11):1832-1843.
Grubb A, Nyman U, Björk J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005;51(8):1420-1431.
Nigro P, Pompilio G, Capogrossi M. Cyclophilin A: a key player for human disease. Cell Death Dis. 2013;4(10):e888.
Satoh K, Shimokawa H, Berk BC. Cyclophilin A. Circ J. 2010;74(11):2249-2256.
Assal HS, Tawfeek S, Rasheed EA, El-Lebedy D, Thabet EH. Serum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitus. Clin Med Insights. 2013;6:S12633.
Chae H-W, Shin J-I, Kwon A-R, Kim H-S, Kim D-H. Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients. J Korean Med Sci. 2012;27(7):784-787.
Jeon YK, Kim MR, Huh JE, et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean Med Sci. 2011;26(2):258-263.
Rao X, Wan M, Qiu C, Jiang C. Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus. Exp Ther Med. 2014;8(3):887-892.
Suzuki Y, Matsushita K, Seimiya M, et al. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes. Clin Chem Lab Med. 2012;50(10):1833-1839.
Brijesh M, Saurav P. Comparative study of significance of serum cystatin-C, serum creatinine and microalbuminuria estimation in patients of early diabetic nephropathy. J Diabetes Metab. 2015;6(490):2.
Ogawa Y, Goto T, Tamasawa N, et al. Serum cystatin C in diabetic patients: not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy. Diabetes Res Clin Pract. 2008;79(2):357-361.
Maahs DM, Prentice N, McFann K, et al. Age and sex influence cystatin C in adolescents with and without type 1 diabetes. Diabetes Care. 2011;34(11):2360-2362.
Konsouh MMF, Al Ashmawy AA, Abdel Ghaffar A, Kamel AS, Ahmed AE-A. Evaluation of serum Cystatin C in type 1 diabetic children and adolescents as an early indicator of diabetic nephropathy. J Am Sci. 2015;11(5):129-136.
Chen H, Li H. Clinical implication of Cystatin C and β2-microglobulin in early detection of diabetic nephropathy. Clin Lab. 2017;63(2):241-247.
Qamar A, Hayat A, Ahmad TM, Khan A, Hasnat M, Tahir S. Serum Cystatin C as an early diagnostic biomarker of diabetic kidney disease in type 2 diabetic patients. J Coll Physicians Surg Pak. 2018;28(4):288-291.
Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin. 2013;97(1):59-74.
Katz ML, Kollman CR, Dougher CE, Mubasher M, Laffel LM. Influence of HbA1c and BMI on lipid trajectories in youths and young adults with type 1 diabetes. Diabetes Care. 2017;40(1):30-37.
El-Maksoud AMA, El Hefnawy MH, Yahya SM, et al. Early predictors of microvascular complications in type 1 diabetic patients. Clin Biochem. 2009;42(13-14):1401-1406.
Kamaleldeen EB, Mohammad HA, Mohamed EF, Askar AG. Microvascular complications in children and adolescents with type 1 diabetes mellitus in Assiut governorate, Eygpt. Egypt Pediatr Assoc Gaz. 2018;66(4):85-90.
Stone ML, Craig ME, Chan AK, Lee JW, Verge CF, Donaghue KC. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care. 2006;29(9):2072-2077.
El Dayem SMA, Nazif HK, EI-Kader MA, El-Tawil M. Study of adiponectin level in diabetic adolescent girls in relation to glycemic control and complication of diabetes. Open Access Maced J Med Scis. 2015;3(4):613.
Hogg RJ, Furth S, Lemley KV, et al. National kidney foundation’s kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003;111(6):1416-1421.
Saunders W. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. 2007.
Hunley TE, Kon V, Ichikawa I. Glomerular circulationand function. In: Pediatric Nephrology. 2009.
Pan C, Avner E. Glomerular filtration. Nelson Textbook of Pediatrics 19th ed Philadelphia, PA: Elsevier Saunders. 2011.
Zahran A, El-Husseini A, Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. American journal of nephrology. 2007;27(2):197-205.
King AJ, Levey AS. Dietary protein and renal function. Journal of the American Society of Nephrology. 1993;3(11):1723-1737.
Viswanathan V, Snehalatha C, Nair M, Ramachandran A. Comparative assessment of cystatin C and creatinine for determining renal function. Indian J Nephrol. 2005;15:91-94.
American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes care. 2013;36(Supplement1):S11-S66.
Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. American journal of kidney diseases. 2001;37(1):S66-S70.
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine. 2013;158(11):825-830.
Brion LP, Fleischman AR, McCarton C, Schwartz GJ. A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth. The Journal of pediatrics. 1986;109(4):698-707.
Schwartz G, Feld L, Langford D. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. The Journal of Urology. 1985;133(1):154-154.
Schwartz G, Haycock G, Edelmann C, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976;58(2):259-263.